StockData

China SXT Pharmaceuticals, Inc. (SXTC) stock

SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 1, 2026Score 4/30
$3.00+0.27 (+9.89%)

Close on Nov 13, 2026Market cap $2.87MP/E –Yield –

China SXT Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

China SXT Pharmaceuticals's price to sales ratio was 1.7× on Nov 11, 2026.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.7×–

More China SXT Pharmaceuticals figures

See a number that looks wrong?